Marshall Edwards elects Robert Mass CMO
This article was originally published in Scrip
Executive Summary
Marshall Edwards, an oncology company, has appointed Dr Robert Mass chief medical officer. Dr Mass joins the companyafter over a decade at Genentech, where he most recently served as head of medical affairs and played a leading role in the clinical development of drugs such as Herceptin (trastuzumab), Tarceva (erlotinib) and Avastin (bevacizumab).